Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ultrasound Obstet Gynecol. 2020 Dec;56(6):901-905. doi: 10.1002/uog.21930.
To determine if large-for-gestational age (LGA) diagnosed during second-trimester ultrasound examination is associated with the development of gestational diabetes mellitus (GDM) and LGA at birth.
This was a retrospective cohort study of all pregnant women who underwent a second-trimester anatomy ultrasound examination between 18 and 22 weeks at our institution from 2012 to 2017. Patients were included in the LGA group if estimated fetal weight and/or fetal abdominal circumference was ≥ 90 percentile for gestational age. Patients with a history of pre-GDM, multiple gestation, preterm delivery, use of betamethasone or fetal anomaly were excluded. The control group consisted of appropriate-for-gestational-age (AGA) pregnancies that were scanned at 18-22 weeks during the study period. AGA was defined as EFW > 10 percentile and ≤ 89 percentile. Prenatal and delivery records were reviewed and demographic and outcome variables were collected. Multivariable logistic regression models were applied to assess the impact of LGA diagnosed in the second trimester on the development of GDM and LGA at birth (birth weight ≥ 90 percentile).
The study population included 756 patients with a LGA fetus and 756 with an AGA fetus on second-trimester ultrasound examination. In patients with a LGA fetus diagnosed during the second-trimester ultrasound examination, the incidence of GDM was 6.0% and the incidence of LGA at birth was 14.9%. Among patients with a LGA fetus in the second trimester, those who developed GDM or LGA at birth were significantly older and were more likely to be obese. Moreover, parity was associated with neonatal LGA (P = 0.0003) but not with GDM (P = 0.82). On multivariable logistic regression analysis with adjustment for age, parity, change in gestational body mass index, obesity, ethnicity and neonatal sex, LGA diagnosed during the second trimester was associated significantly with GDM (adjusted odds ratio (aOR), 2.54; 95% CI, 1.29-5.03; P = 0.007) and LGA at birth (aOR, 6.85; 95% CI, 3.60-13.05; P < 0.0001).
LGA diagnosed during second-trimester ultrasound examination is associated with the development of GDM and LGA at birth, independent of known risk factors, and could be used to identify these women earlier for intervention. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
确定在妊娠中期超声检查中诊断的巨大儿(LGA)是否与妊娠期糖尿病(GDM)和出生时 LGA 的发生有关。
这是一项回顾性队列研究,纳入了 2012 年至 2017 年期间在我院进行 18-22 周妊娠中期超声检查的所有孕妇。如果估计胎儿体重和/或胎儿腹围≥胎龄第 90 百分位,则将患者归入 LGA 组。排除有妊娠前糖尿病、多胎妊娠、早产、使用倍他米松或胎儿畸形病史的患者。对照组由在研究期间 18-22 周进行扫描的适合胎龄(AGA)妊娠组成。AGA 定义为 EFW >第 10 百分位且≤第 89 百分位。回顾性分析产前和分娩记录,收集人口统计学和结局变量。应用多变量逻辑回归模型评估妊娠中期诊断的 LGA 对 GDM 和出生时 LGA(出生体重≥第 90 百分位)的发生的影响。
研究人群包括 756 例妊娠中期超声检查中 LGA 胎儿和 756 例 AGA 胎儿的患者。在妊娠中期超声检查中诊断为 LGA 的患者中,GDM 的发生率为 6.0%,出生时 LGA 的发生率为 14.9%。在妊娠中期 LGA 胎儿中,发生 GDM 或出生时 LGA 的患者年龄明显较大,且更可能肥胖。此外,产次与新生儿 LGA 相关(P=0.0003),但与 GDM 无关(P=0.82)。多变量逻辑回归分析显示,校正年龄、产次、妊娠体重指数变化、肥胖、种族和新生儿性别后,妊娠中期诊断的 LGA 与 GDM(校正比值比[aOR],2.54;95%置信区间[CI],1.29-5.03;P=0.007)和出生时 LGA(aOR,6.85;95%CI,3.60-13.05;P<0.0001)显著相关。
妊娠中期超声检查中诊断的 LGA 与 GDM 和出生时 LGA 的发生有关,与已知的危险因素无关,可用于更早识别这些女性并进行干预。版权所有©2019 ISUOG。由 John Wiley & Sons Ltd 出版。